For those impacted by brain tumors—patients, survivors, family members and those who harbor loss and cherished memories—the weekend of Oct. 22-23 is among the most meaningful of the year. It marks the Midwest Regional Brain Tumor Conference and Walk Ahead for a Brain Tumor Cure.
Patient Education Event
The conference, presented by the Brain Tumor Center at the University of Cincinnati Gardner Neuroscience Institute and the UC Cancer Institute, offers insights, information and inspiration from more than a dozen brain tumor experts. It will be held from 8 a.m. to noon Saturday, Oct. 22, at the Sharonville Convention Center. Registration and continental breakfast begin at 8 a.m.
There is no charge to attend, but registration is requested. Call 513-584-8642 or register online.
Presenters include specialists in endocrinology, hematology oncology, neurosurgery, otolaryngology, radiation oncology and radiology. Symposium Director Luke Pater, MD, a UC Health radiation oncologist and a faculty member at the College of Medicine, will provide an overview of proton therapy, an advanced type of radiation therapy now being offered at the Cincinnati Children’s/UC Health Proton Therapy Center in Liberty Township, Ohio.
Other presentation topics include long-term steroid therapy and how to make the most of MyChart. Brandon Schlunt, chef at HealthSavor, will provide a cooking demonstration focused on the concept of food as medicine. Brain tumor specialists also will offer breakout sessions dedicated to specific tumor types (glioma, acoustic neuroma, meningioma, pituitary adenoma) as well as wellness and meditation.
Brain Tumor Fundraising Event
Walk Ahead, the largest regional fundraiser for brain tumor education and research, will be held Sunday, Oct. 23, at Sawyer Point in downtown Cincinnati. The 5K run will begin at 8:30 a.m. and the walk at 9 a.m.
Proceeds support the annual symposium and research at the UC Brain Tumor Center. Specifically, Brain Tumor Center researchers use Walk Ahead funds to study 1) the major pathways used by cancer genes; 2) the specific proteins that play a role in the spread of cancer cells; and 3) the compounds that inhibit the ability of cancer cells to utilize energy.
To register, donate or volunteer, please visit www.walkahead.org. For sponsorship information, contact Alexandra Lolli at 513-558-6903 or Alexandra.Lolli@uc.edu.
Last year’s Walk Ahead drew 3,383 participants from 19 states and raised more than $360,000, bringing the event’s cumulative fund-raising total to more than $1.3 million. The 2016 event co-chairs are Rick June and Michael Perez. Presenting sponsor is Anthem BlueCross BlueShield.
The American Brain Tumor Association estimates that 70,000 primary brain tumors (those that originate in the brain) are diagnosed each year, about 35 percent of which are malignant. The incidence of metastatic brain tumors (those that have spread from another part of the body) is far higher, with more than 170,000 cases diagnosed each year.
The UC Brain Tumor Center treats patients with complex tumors of the brain, head, neck and central nervous system. The center’s multidisciplinary team includes specialists in radiation oncology, neurosurgery, neuro-oncology, otolaryngology, neuroophthalmology, physical medicine and rehabilitation, restorative medicine, neuropathology, neuroradiology and integrative medicine. Ongoing collaboration among expert team members at a weekly Multidisciplinary Tumor Board Conference, combined with state-of-the-art technology, ensures the best possible treatment for patients with primary or metastatic brain tumors.